Blood Purification Equipment Market Increasing Prevalence of Chronic Kidney Diseases to Drive Global Blood Purification Equipment Market Growth

The blood purification equipment market was valued at US$ 3,881.3 million in 2018 and it is projected to reach US$ 5,502.8 million in 2027; it is expected to grow at a CAGR of 4.0% from 2019 to 2027.

Blood purification equipment work similar to the dialysis equipment. These equipment use thin fibers to capture and remove viruses and filters the blood. The equipment requires the drawing of blood through an artery, which is sent through a tube into the equipment, then back into the body. The growth of the global blood purification equipment market is attributed to the increasing prevalence of chronic kidney diseases, technological advancements in hemodialysis and rising adoption of home based healthcare. However, high cost of blood purification and complications associated with blood purification are the major factor hindering the market growth.

Request for sample Research copy at: https://www.theinsightpartners.com/sample/TIPHE100001301/

Key findings from the report

• In terms of product, the global blood purification equipment market is segmented into continuous renal replacement therapy (CRRT) device, hemoperfusion device, plasma exchange device, hemodialysis device and blood filtration device. In 2018, the hemodialysis device segment held largest share of the market. However, the continuous renal replacement therapy (CRRT) device segment is estimated to register the highest CAGR during the forecast period.
• In terms of end user, the global blood purification equipment market is segmented into hospitals, ambulatory surgical centers and others. The hospitals segment held the largest share of the market in 2018. In contrast, the others segment i.e. specialty clinics, home care and academics & research institutes is estimated to grow at the fastest rate during the forecast period.
• The major players operating in the blood purification equipment market include, CytoSorbents Corporation, Fresenius Medical Care. (NxStage Medical, Inc.), Spectral Medical Inc., Baxter International Inc., Nikkiso Co, Inc., Haemonetics Corporation, B. Braun Melsungen AG, Medtronic plc (Bellco), Jafron Biomedical Co., Ltd., and Kaneka Medix Corp and others. The market has carried out various organic and inorganic growth strategies in the market. The organic strategies were conducted majorly and these strategies have assisted in strengthening their product offering in the market.

The market for blood purification equipment is expected to grow significantly due to factors such as rising increasing prevalence of chronic kidney diseases, technological advancements in hemodialysis and rising adoption of home based healthcare. However, the market is likely to experience restriction on its growth owing to the factors such as high cost of blood purification and risks associated with blood purification.

The most common type of renal diseases include chronic kidney diseases (CKD). CKD refers to a long term condition, commonly caused due to high blood pressure and doesn’t improve over time. The CKD occurs due to inability of the kidneys to perform their normal function. Over the time, human kidneys stop working completely and requires performing dialysis that helps to filter and purify the blood with the help of an external machine. These machines known as hemodialysis devices contributes a major share in the blood purification equipment market. Thus, the increasing number of patients suffering with renal disorders that require regular dialysis procedures are expected to increase the demand of the equipment thereby fostering the market growth.

Adults suffering with high blood pressure, diabetes or both are at high risks of developing chronic kidney diseases. According to the Centers for Disease Control and Prevention (CDC), 30 million people that approximates to 15% of the adult US population were estimated to have chronic kidney disease in 2017. Of these patients, diabetes and high blood pressure was reported to be a cause for 44% and 29% population respectively.

The mortality rate due to chronic kidney diseases has also witnessed a surge over years. The 2015 study of Global Burden of Diseases conducted by the World Health Organization (WHO) states that 1.2 million people died from kidney failure, which increased by 32% from 2005. Furthermore, the WHO also reported that approximately 2.3 million patients suffering with end-stage kidney disease died due to lack of access to dialysis. The incorporation of multiple hemodialysis units around the globe is thus expected to drive the growth of the market.

Place an Order Now: https://www.theinsightpartners.com/buy/TIPHE100001301/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email- sales@theinsightpartners